Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies
Clinical trial NCT02991898 · TERMINATED
Trial details
- NCT number
- NCT02991898
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-16
- Primary completion
- 2019-06-20
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.